These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10688282)

  • 1. The effect of hormone replacement therapy and exercise on cardiovascular disease risk factors in postmenopausal women.
    Haddock BL; Marshak HP; Mason JJ; Blix G
    Sports Med; 2000 Jan; 29(1):39-49. PubMed ID: 10688282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyslipidemia in midlife women: Approach and considerations during the menopausal transition.
    Torosyan N; Visrodia P; Torbati T; Minissian MB; Shufelt CL
    Maturitas; 2022 Dec; 166():14-20. PubMed ID: 36027726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of menstrual status on lipid profile: A cross-sectional study in a tertiary care hospital in Nepal.
    Adhikaree J; Shrestha R; Bomjan P; Shrestha A; Pokharel S; Acharya R; Siwakoti A; Pokhrel R; Marzo RR; Rajbhandari PMS; Acharya S
    Post Reprod Health; 2023 Dec; 29(4):195-200. PubMed ID: 37907067
    [No Abstract]   [Full Text] [Related]  

  • 4. Physical activity levels and associated cardiovascular disease risk factors among postmenopausal rural women of Bangladesh.
    Barua L; Faruque M; Chandra Banik P; Ali L
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S161-S166. PubMed ID: 30595250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogens and cardiovascular disease risk revisited: the Women's Health Initiative.
    Howard BV; Rossouw JE
    Curr Opin Lipidol; 2013 Dec; 24(6):493-9. PubMed ID: 24184944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of exercise on heart rate variability in perimenopausal and postmenopausal women.
    Fang M; Zhang P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Apr; 49(4):516-525. PubMed ID: 39019780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardio-Metabolic Health and HRT in Menopause: Novel Insights in Mitochondrial Biogenesis and RAAS.
    Renke G; Kemen E; Scalabrin P; Braz C; Baesso T; Pereira MB
    Curr Cardiol Rev; 2023; 19(4):e060223213459. PubMed ID: 36748220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of diet, physical activity, lipid status and glycoregulation in estimation of score (systematic coronary risk evaluation) for ten years in postmenopausal women.
    Kocić R; Spirovski D; Cirić V; Velija-Asimi Z
    Bosn J Basic Med Sci; 2007 Aug; 7(3):197-204. PubMed ID: 17848142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Secondary Amenorrhea on Cardiovascular Disease Risk in Physically Active Women: A Systematic Review and Meta-Analysis.
    Tegg NL; Myburgh C; O'Donnell E; Kennedy M; Norris CM
    J Am Heart Assoc; 2024 Mar; 13(6):e033154. PubMed ID: 38497482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in CVD risk factors in the activity counseling trial.
    Baruth M; Wilcox S; Sallis JF; King AC; Marcus BH; Blair SN
    Int J Gen Med; 2011 Jan; 4():53-62. PubMed ID: 21403793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Awareness, accuracy, and predictive validity of self-reported cholesterol in women.
    Huang PY; Buring JE; Ridker PM; Glynn RJ
    J Gen Intern Med; 2007 May; 22(5):606-13. PubMed ID: 17370032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menopause transition and cardiovascular disease risk.
    Uddenberg ER; Safwan N; Saadedine M; Hurtado MD; Faubion SS; Shufelt CL
    Maturitas; 2024 Jul; 185():107974. PubMed ID: 38555760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical and psychological aspects of hormone replacement therapy in postmenopausal women: points of view from a cardiologist and a psychotherapist.
    Cohn PF; Cohn JK
    Clin Cardiol; 1998 Dec; 21(12):875-7. PubMed ID: 9853177
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeting estrogen receptor signaling for treating heart failure.
    Qian C; Liu J; Liu H
    Heart Fail Rev; 2024 Jan; 29(1):125-131. PubMed ID: 37783987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Exercise Therapy on CVD Risk Factors in Women.
    Hur S; Kim SR
    J Phys Ther Sci; 2014 Sep; 26(9):1367-70. PubMed ID: 25276017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose estrogen therapy does not change postexercise hypotension, sympathetic nerve activity reduction, and vasodilation in healthy postmenopausal women.
    Oneda B; Forjaz CL; Bernardo FR; Araújo TG; Gusmão JL; Labes E; Abrahão SB; Mion D; Fonseca AM; Tinucci T
    Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1802-8. PubMed ID: 18775846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined effects of 17β-estradiol and exercise training on cardiac apoptosis in ovariectomized rats.
    Lin YY; Chen JS; Wu XB; Shyu WC; Chaunchaiyakul R; Zhao XL; Kuo CH; Cheng YJ; Yang AL; Lee SD
    PLoS One; 2018; 13(12):e0208633. PubMed ID: 30571718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intrinsic aerobic capacity and ovariectomy on voluntary wheel running and nucleus accumbens dopamine receptor gene expression.
    Park YM; Kanaley JA; Padilla J; Zidon T; Welly RJ; Will MJ; Britton SL; Koch LG; Ruegsegger GN; Booth FW; Thyfault JP; Vieira-Potter VJ
    Physiol Behav; 2016 Oct; 164(Pt A):383-9. PubMed ID: 27297873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral density and cardiovascular risk factors in postmenopausal women with coronary artery disease.
    Alissa EM; Alnahdi WA; Alama N; Ferns GA
    Bonekey Rep; 2015; 4():758. PubMed ID: 26587227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.